(Q50898088)

25 March 2018

title

Pneumonia: the impact of risk factors on the outcome of treatment with meropenem and ceftazidime. (English)

1 reference

25 March 2018

1 reference

Finch RG

1

1 reference

25 March 2018

Pemberton K

series ordinal

2

1 reference

25 March 2018

Gildon KM

series ordinal

3

1 reference

25 March 2018

publication date

1 February 1998

1 reference

25 March 2018

published in

Journal of Chemotherapy

1 reference

25 March 2018

volume

10

1 reference

25 March 2018

issue

1

1 reference

25 March 2018

page(s)

35-46

1 reference

25 March 2018

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.1.35

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.1.35

Aetiology and outcome of severe community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.1.35

Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.1.35

Predicting death in patients hospitalized for community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.1.35

Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.1.35

Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.1.35

21 January 2018

Identifiers

DOI

10.1179/JOC.1998.10.1.35

1 reference

25 March 2018

1 reference

25 March 2018